Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) COO Michael Willem Waters sold 5,793 shares of Teladoc Health stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $73,513.17. Following the completion of the sale, the chief operating officer now directly owns 64,881 shares of the company’s stock, valued at approximately $823,339.89. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Michael Willem Waters also recently made the following trade(s):
- On Friday, February 2nd, Michael Willem Waters sold 4,523 shares of Teladoc Health stock. The stock was sold at an average price of $19.18, for a total value of $86,751.14.
Teladoc Health Stock Down 1.6 %
NYSE:TDOC opened at $12.78 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.82 and a quick ratio of 3.47. The business’s 50-day simple moving average is $14.40 and its two-hundred day simple moving average is $17.51. Teladoc Health, Inc. has a 52 week low of $12.53 and a 52 week high of $30.41.
Institutional Investors Weigh In On Teladoc Health
Large investors have recently made changes to their positions in the company. ICA Group Wealth Management LLC bought a new stake in shares of Teladoc Health in the fourth quarter worth about $28,000. Hexagon Capital Partners LLC increased its holdings in shares of Teladoc Health by 204.4% in the fourth quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after purchasing an additional 1,065 shares during the last quarter. RIA Advisory Group LLC bought a new stake in shares of Teladoc Health in the fourth quarter worth about $36,000. GAMMA Investing LLC bought a new stake in shares of Teladoc Health in the fourth quarter worth about $41,000. Finally, Principal Securities Inc. bought a new stake in shares of Teladoc Health in the fourth quarter worth about $45,000. 76.82% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on the company. Royal Bank of Canada dropped their price target on Teladoc Health from $25.00 to $18.00 and set an “outperform” rating on the stock in a research note on Friday, April 26th. Wells Fargo & Company dropped their price target on Teladoc Health from $17.00 to $15.00 and set an “equal weight” rating on the stock in a research note on Monday, April 29th. DA Davidson dropped their price target on Teladoc Health from $22.00 to $18.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 21st. SVB Leerink assumed coverage on Teladoc Health in a research note on Monday, February 26th. They issued a “market perform” rating and a $17.00 price target on the stock. Finally, Evercore ISI dropped their price target on Teladoc Health from $15.00 to $14.00 and set an “in-line” rating on the stock in a research note on Friday, April 26th. Twelve equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $18.73.
View Our Latest Report on Teladoc Health
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Recommended Stories
- Five stocks we like better than Teladoc Health
- 3 Grocery Stocks That Are Proving They Are Still Essential
- MarketBeat Week in Review – 4/29 – 5/3
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Investing In Automotive Stocks
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.